These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: evidence for processing of cell-bound IGFBP-3. Conover CA Endocrinology; 1991 Dec; 129(6):3259-68. PubMed ID: 1720092 [TBL] [Abstract][Full Text] [Related]
3. Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Conover CA; Ronk M; Lombana F; Powell DR Endocrinology; 1990 Dec; 127(6):2795-803. PubMed ID: 1701128 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Conover CA Endocrinology; 1992 Jun; 130(6):3191-9. PubMed ID: 1375895 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Conover CA; Bale LK; Durham SK; Powell DR Endocrinology; 2000 Sep; 141(9):3098-103. PubMed ID: 10965879 [TBL] [Abstract][Full Text] [Related]
7. Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. Conover CA; Kiefer MC; Zapf J J Clin Invest; 1993 Mar; 91(3):1129-37. PubMed ID: 7680662 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205 [TBL] [Abstract][Full Text] [Related]
9. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF) binding protein-3 regulation of IGF-I is altered in an acidic extracellular environment. Forsten KE; Akers RM; San Antonio JD J Cell Physiol; 2001 Dec; 189(3):356-65. PubMed ID: 11748593 [TBL] [Abstract][Full Text] [Related]
11. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Arai T; Busby W; Clemmons DR Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319 [TBL] [Abstract][Full Text] [Related]
12. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: role of heparan sulfate proteoglycans. Yang YW; Yanagishita M; Rechler MM Endocrinology; 1996 Oct; 137(10):4363-71. PubMed ID: 8828497 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-3 inhibits porcine granulosa cell function in vitro. Samaras SE; Hammond JM Am J Physiol; 1995 Jun; 268(6 Pt 1):E1057-64. PubMed ID: 7541943 [TBL] [Abstract][Full Text] [Related]
15. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Reeve JG; Morgan J; Schwander J; Bleehen NM Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401 [TBL] [Abstract][Full Text] [Related]
16. Bioactivity of a 29-kilodalton insulin-like growth factor binding protein-3 fragment present in excess in chronic renal failure serum. Durham SK; Mohan S; Liu F; Baker BK; Lee PD; Hintz RL; Conover CA; Powell DR Pediatr Res; 1997 Sep; 42(3):335-41. PubMed ID: 9284274 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity. Ricort JM; Binoux M Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells. Besset V; Le Magueresse-Battistoni B; Collette J; Benahmed M Endocrinology; 1996 Jan; 137(1):296-303. PubMed ID: 8536626 [TBL] [Abstract][Full Text] [Related]
19. Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Bach LA; Hsieh S; Brown AL; Rechler MM Endocrinology; 1994 Nov; 135(5):2168-76. PubMed ID: 7525263 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of insulin-like growth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling. Devi GR; Yang DH; Rosenfeld RG; Oh Y Endocrinology; 2000 Nov; 141(11):4171-9. PubMed ID: 11089550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]